Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 09:38
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 700°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
±¹³» õ½Ä Áø·áÁöħ, ICS/LABA ºñÁß À¯Áö
ÀÓ¼¼Çü ±âÀÚ
2023-04-03 17:39
[Sub Story]
LABA/LAMA/ICS ÁßÁõ õ½Ä¡¤COPD¿¡ À¯È¿ÇÑ Ä¡·áÀü·«
ÀÓ¼¼Çü ±âÀÚ
2023-04-03 17:05
[Sub Story]
¡®ICS/Æ÷¸£¸ðÅ×·Ñ¡¯ Áß½É Ä¡·áÀü·« À¯Áö
ÀÓ¼¼Çü ±âÀÚ
2023-04-03 16:42
[Interview]
¡°±¹³» ÀÓ»óÇöÀå °í·ÁÇÑ Ãµ½Ä °ü¸®Àü·« ¸ÂÃç ³ª°¥ °Í¡±
ÀÓ¼¼Çü ±âÀÚ
2023-04-03 16:20
[Late Breaking Studies]
º£Å¬·Î¸ÞŸ¼Õ/Æ÷¸£¸ðÅ×·Ñ, ¸®¾ó¿ùµå¿¡¼ õ½Ä Áõ»ó¡¤Æó±â´É °³¼± ÀÔÁõ
ÀÓ¼¼Çü ±âÀÚ
2023-04-03 16:15
¶óÀÎ
[Interview]
¡°È¿°ú-¾ÈÀü¼º ±ÕÇü ÀâÈù ICS/LABA, º£Å¬·Î¸ÞŸ¼Õ/Æ÷¸£¸ðÅ×·Ñ¡±
ÀÓ¼¼Çü ±âÀÚ
2023-04-03 16:05
[Deep in Guideline]
ºñ°³» ½ºÅ×·ÎÀ̵å/Ç×È÷½ºÅ¸¹ÎÁ¦ º´¿ë¿ä¹ý »ç¿ë Á¦½Ã
ÀÓ¼¼Çü ±âÀÚ
2023-04-03 15:06
[Late Breaking Studies]
Æå¼ÒÆ䳪µò, ºü¸£°í ¾ÈÀüÇÑ 2¼¼´ë Ç×È÷½ºÅ¸¹ÎÁ¦
ÀÓ¼¼Çü ±âÀÚ
2023-04-03 14:45
[Sub Story]
¡°ÀþÀº ¼ºÀÎ °íÇ÷¾Ð ȯÀÚ ÀÎÁöµµ, ¿©ÀüÇÑ °úÁ¦¡±
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 17:35
[Deep in Guideline]
½ÉÇ÷°üÀ§Ç衤¸ÂÃãÄ¡·á À§ÇÑ Ç÷¾Ð ºÐ·ù ¼¼ºÐÈ
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 16:28
¶óÀÎ
[Interview]
¡°±¹»ê SGLT-2¾ïÁ¦Á¦ À̳ªº¸±Û¸®Ç÷ÎÁø
¿ä´ç¹èÃâ·® ´Ã¸° ±¸Á¶Àû Ư¡¿¡ °Á¡ÀÖ´Ù¡±
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 15:27
[Cover Story]
ºñ¸¸ Ä¡·á¾à¹°, GLP-1RA ´ÙÀ½À¸·Î ³ª¾Æ°£´Ù
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 14:50
[Sub Story]
¡°GLP-1RA ±â¹Ý Ä¡·áÁ¦ ¾àÁø °è¼ÓµÉ °Í¡±
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 14:37
[Deep in Guideline]
Á¤½Å°Ç°Áúȯ °ü·Ã ºñ¸¸ À§Çè °Á¶
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 14:30
[Sub Story]
¼¼¸¶±Û·çŸÀ̵塤¸®¶ó±Û·çŸÀ̵å ÁÖ¿ä Àü·«À¸·Î ±Ç°í
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 14:12
¶óÀÎ
[Conference Report]
½Ç·Î½ºÅ¸Á¹, ISMN ¸¸³ª ³úÁ¹Áß¡¤ÀÎÁö±â´ÉÀå¾Ö ¿¹¹æÈ¿°ú ÀÔÁõ
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 13:53
[Conference Report]
ÇãÇ÷¼º ³úÁ¹Áß¿¡ ´ëÇÑ NOAC È¿°ú È®ÀÎ
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 13:45
[Conference Report]
°¡´É¼º ´Ù½Ã º¸ÀÎ Å׳ØÅ×ÇöóÁ¦
ÀÓ¼¼Çü ±âÀÚ
2023-03-10 13:41
[Sub Story]
Ç÷´çÀÌ»ó µ¿¹Ý Áö¹æ°£ 20~30´ë¿¡¼ °¡Àå ³ô¾Æ
ÀÓ¼¼Çü ±âÀÚ
2023-02-07 10:13
[Interview]
¡°´ë»çÁúȯÀÇ ¡®°æ°íµî¡¯ Áö¹æ°£ÀÇ ½É°¢¼º ÀνÄÇؾߡ±
ÀÓ¼¼Çü ±âÀÚ
2023-02-07 10:06
-
1
2
3
4
5
6
7
8
9
10
´ÙÀ½
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top